Lundbeckfond Invest A/S

Lundbeckfond Invest A/S has filed trades across 5 companies (mainly through SEC (Form 4)), most often in IO Biotech, Inc., Lexeo Therapeutics, Inc. and scPharmaceuticals Inc. We count 14 filings; the first trade dates from 21 November 2017 and the latest from 7 November 2023.

No open-market sale appears; the market trades are 5 purchases worth €42.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. Since January 2023: 1 purchase and no sales on the market.

Half of the purchases are above €3.3M and half below. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 9 November 2023: a transaction, in Lexeo Therapeutics, Inc. The last purchase on record was published on 9 November 2023, which is 1,079 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.